Abstract

IntroductionAdiponectin is an adipokine that regulates energy metabolism and insulin sensitivity, but recent studies have pointed also to a role in inflammation and arthritis. The purpose of the present study was to investigate the association and effects of adiponectin on inflammation and cartilage destruction in osteoarthritis (OA).MethodsCartilage and blood samples were collected from 35 male OA patients undergoing total knee replacement surgery. Preoperative radiographs were evaluated using Ahlbäck classification criteria for knee OA. Circulating concentrations of adiponectin and biomarkers of OA, that is, cartilage oligomeric matrix protein (COMP) and matrix metalloproteinase 3 (MMP-3), were measured. Cartilage samples obtained at the time of surgery were cultured ex vivo, and the levels of adiponectin, nitric oxide (NO), IL-6, MMP-1 and MMP-3 were determined in the culture media. In addition, the effects of adiponectin on the production of NO, IL-6, MMP-1 and MMP-3 were studied in cartilage and in primary chondrocyte cultures.ResultsPlasma adiponectin levels and adiponectin released from OA cartilage were higher in patients with the radiologically most severe OA (Ahlbäck grades 4 and 5) than in patients with less severe disease (Ahlbäck grades 1 to 3). Plasma adiponectin concentrations correlated positively with biomarkers of OA, that is, COMP (r = 0.55, P = 0.001) and MMP-3 (r = 0.34, P = 0.046). Adiponectin was released by OA cartilage ex vivo, and it correlated positively with production of NO (r = 0.43, P = 0.012), IL-6 (r = 0.42, P = 0.018) and MMP-3 (r = 0.34, P = 0.051). Furthermore, adiponectin enhanced production of NO, IL-6, MMP-1 and MMP-3 in OA cartilage and in primary chondrocytes in vitro in a mitogen-activated protein kinase (MAPK)-dependent manner.ConclusionsThe findings of this study show that adiponectin is associated with, and possibly mediates, cartilage destruction in OA.

Highlights

  • Adiponectin is an adipokine that regulates energy metabolism and insulin sensitivity, but recent studies have pointed to a role in inflammation and arthritis

  • In multiple regression analysis, where serum cartilage oligomeric matrix protein (COMP) was set as a dependent variable and plasma adiponectin, age and body mass index (BMI) were set as predictive variables, A

  • We found that adiponectin was associated with markers and signs of cartilage degradation, that is, with circulating concentrations of COMP and matrix metalloproteinase (MMP)-3 and with radiographic severity of OA

Read more

Summary

Introduction

Adiponectin is an adipokine that regulates energy metabolism and insulin sensitivity, but recent studies have pointed to a role in inflammation and arthritis. The purpose of the present study was to investigate the association and effects of adiponectin on inflammation and cartilage destruction in osteoarthritis (OA). Tissues in the joint, including synovium, meniscus, osteophytes, cartilage, bone and fat, have been reported to produce adiponectin [10,11,12]. In arthritis models and in joint tissues, adiponectin has been postulated to have both pro- and anti-inflammatory effects. Adiponectin has been reported to increase the production of cartilage-degrading matrix metalloproteinase (MMP) enzymes, cytokines and prostaglandin E2 in chondrocytes and in synovial fibroblasts [11,14,15,16,17,18,19]. High circulating adiponectin was found to correlate with cartilage degradation in patients with rheumatoid arthritis (RA) [21,22,23], partly contradictory results have been published [24,25]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call